Mesoblast (MESO) Interest & Investment Income (2015 - 2025)
Mesoblast's (MESO) quarterly Interest & Investment Income came in at $2.6 million in Q4 2025, up 508.28% year-on-year from $435000.0 in Q4 2024, and up 508.28% quarter-over-quarter from $435000.0 in Q4 2024.
Mesoblast (MESO) Interest & Investment Income (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Interest & Investment Income across 11 years of filings, most recently posting $2.6 million for Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $2.6 million, up 508.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.6 million (up 508.28% YoY), and the FY2022 annual result was $3000.0, down 86.36% from the prior year.
- Interest & Investment Income came in at $2.6 million for Q4 2025 at Mesoblast, up from $435000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.6 million in Q4 2025 to a low of $1000.0 in Q4 2021.
- The 5-year median for Interest & Investment Income is $214000.0 (2022), against an average of $523444.4.
- Across the five-year window, Interest & Investment Income sank 95.68% in 2021 and jumped 42700.0% in 2023, its largest moves.
- Mesoblast's Interest & Investment Income stood at $1000.0 in 2021, then surged by 21300.0% to $214000.0 in 2022, then jumped by 321.96% to $903000.0 in 2023, then sank by 51.83% to $435000.0 in 2024, then jumped by 508.28% to $2.6 million in 2025.
- The last three Interest & Investment Income figures came in at $2.6 million (Q4 2025), $435000.0 (Q4 2024), and $903000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 435,000.00 |
| Dec 31, 2023 | 903,000.00 |
| Mar 31, 2023 | 428,000.00 |
| Dec 31, 2022 | 214,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 23,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 533,000.00 |
| Dec 31, 2019 | 413,000.00 |
| Sep 30, 2019 | 176,000.00 |
| Mar 31, 2019 | 491,000.00 |
| Dec 31, 2018 | 284,000.00 |
| Sep 30, 2018 | 131,000.00 |
| Mar 31, 2018 | 261,000.00 |
| Dec 31, 2017 | 182,000.00 |
| Sep 30, 2017 | 68,000.00 |